Supreme Announces Proposed Name Change and Additional Line of Business
29 Januar 2014 - 1:00PM
Marketwired
Supreme Announces Proposed Name Change and Additional Line of
Business
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan 29, 2014) -
SUPREME RESOURCES LTD. ("Supreme" or the "Corporation")
(TSX-VENTURE:SPR) announces that it will, subject to regulatory
approval, change its name to Supreme Pharmaceuticals Inc. in
conjunction with its recent decision to pursue interests in
pharmaceuticals or biomedical devices.
David Stadnyk, President, stated "The current management team of
the Corporation has had highly successful experiences with finding
and developing early stage pharmaceutical or biomedical devices, so
given the moribund junior mining sector, we feel that if we can
supply an additional line of business for Supreme, shareholders
will benefit. Some of the pharmaceutical and biomedical companies
that management has co-founded include Pharmaxis Ltd., Eupraxia
Pharmaceuticals Inc. (of which Mr. Tsafalas is currently a
financial executive), and Praxis Pharmaceuticals. We have no plans
to dispose of or shelve our mineral exploration properties, and
will continue to work on them as the opportunities present
themselves. In the meantime, we are evaluating several significant
opportunities to advance on in the pharma field."
About Supreme Resources Ltd.:
Supreme Resources Ltd. is a junior exploration company with
advanced base and precious metals projects located in producing
mining districts of British Columbia, Canada. Supreme Resources'
goal is to increase shareholder value by developing exploration
projects that have the potential of becoming new discoveries.
Website: www.supremeresourcesltd.com
Further news will be forthcoming in the near future.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Statements in this press release other than purely historical
factual information, including statements relating to revenues or
profits, or the Company's future plans and objectives, or expected
sales, cash flows, and capital expenditures constitute
forward-looking statements. Forward-looking statements are based on
numerous assumptions and are subject to all of the risks and
uncertainties inherent in the Company's business, including risks
inherent in the technology history. There can be no assurance that
such forward-looking statements will prove to be accurate, as
actual results and future events could differ materially from those
anticipated in such statements. Accordingly, readers should not
place undue reliance on such statements. Except in accordance with
applicable securities laws, the Company expressly disclaims any
obligation to update any forward-looking statements or
forward-looking statements that are incorporated by reference
herein. This news release does not constitute an offer to sell, or
a solicitation of an offer to buy any of the Company's securities
set out herein in the United States, or to, or for the benefit or
account of, a U.S. Person or person in the United States.
David
StadnykPresident604.428.0511info@supremepharmaceuticals.com
Supreme Resources Ltd. (TSXV:SPR)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Supreme Resources Ltd. (TSXV:SPR)
Historical Stock Chart
Von Jul 2023 bis Jul 2024